"Providing quality vision care to the Brentwood community is the number one goal at Primary Eyecare Group. Our office has knowledgeable doctors and friendly staff members dedicated to fulfilling all of your eye care needs including: comprehensive eye exams, glasses & designer frames, contact lenses and emergency care."

During the past decade, Primary Eyecare Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Primary Eyecare Group" #1 sponsor was "Johnson & Johnson Vision Care, Inc." with 2 trials, followed by "Vision Service Plan" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Bausch & Lomb Incorporated" with 1 trials sponsored and "SynergEyes, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Primary Eyecare Group" #1 collaborator was "Foresight Regulatory Strategies, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Primary Eyecare Group" are "Myopia" (2 trials), "Refractive Errors" (2 trials), "Astigmatism" (1 trials), "Dry Eye Syndromes" (1 trials) and "Refractive Error - Myopia Bilateral" (1 trials). Many other conditions were trialed in "Primary Eyecare Group" in a lesser frequency.

Most popular intervention types in "Primary Eyecare Group" are "Device" (5 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atropine 0.01% Ophthalmic Solution" (1 trials), "Atropine 0.1% Ophthalmic Solution" (1 trials), "Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)" (1 trials), "Phase A - olifilcon B with Tangible Coatings" (1 trials) and "Phase B - etafilcon A with Tangible Coatings" (1 trials). Other intervention names were less common.

The vast majority of trials in "Primary Eyecare Group" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Primary Eyecare Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Primary Eyecare Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Primary Eyecare Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".